Queen Elisabeth Medical Foundation

UGent

Dr. Marta Scarioni

Mapping signature features and neuroanatomical correlates of hallucinations and delusions in neurodegenerative cognitive disorders

Prof. Thomas Tarnaud

Cell-type selectivity of transcranial focused ultrasound for epilepsy treatmentC

Dr. Lien Van Hoecke

The skull bone marrow: a novel player and therapeutic target in the brain–immune axis during meningitis

UAntwerpen

Dr. Duc Nam Nguyen

Breaking the Geometry of Cross-Dementia Landscape for Early Diagnosis and Drug Target Identification

Prof. Dr. Daniele Bertoglio

Investigating Msh3 modulation as a novel therapeutic strategy for the treatment of Huntington’ Disease

PhD Sokolova Dimitra

Targeting Microglial MHCII and Regulatory T Cells to Modulate Alzheimer’s disease Progression

Dr. Cristina Vicente

Dissecting the transcriptional regulatory landscape of TMEM106B

KU Leuven

Dr. Eliana Nachman

Synaptic Homeostasis and Autophagy Regulation in the Etiology of Parkinsonism

PhD Catherine Marneffe

CALM-GBM: Circuit control by Astrocytes Located in Microenvironment of Glioblastoma

PhD Iris Verbinnen

Identifying disease-critical neural cell types and pathways to guide new treatment approaches for Houge-Janssens syndrome type 2 (HJS2)

UCLouvain

PhD Everard Gauthier

taVNS with iVR for stroke rehabilitation

Dr. Masori Pegah

Biomarker Research into Dysregulated Immunity in ALS (ALS-BRiDGE)

UHasselt

PhD Melanie Loix

Clocking in foamy microglia to curb and reverse inflammatory demyelination

Dr. Sam Vanherle

Targeting transforming growth factor beta 3-driven phospholipid synthesis to enhance oligodendrocyte differentiation in multiple sclerosis

ULB

PhD Simon Desidero

Uncovering the molecular basis of somatosensory neuron diversification

ULiège

PhD Anneline Pinson

Implication of GnRH in the neocortical developmental alterations induced by endocrine disrupting chemicals